SCHEMBL3100413

SCHEMBL3100413

CCOC(=O)Cc1nc2ccccc2s1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.75
KMT2A Q03164 4/20 0.75
MEN1 O00255 3/20 0.75
KDM4E B2RXH2 3/20 0.75
GAA P10253 1/20 0.75
MAPK1 P28482 3/20 0.64
CYP1A2 P05177 1/20 0.61
CYP2C19 P33261 1/20 0.61
SMN1; SMN2 Q16637 5/20 0.60
RAB9A P51151 4/20 0.60
NPC1 O15118 3/20 0.60
L3MBTL1 Q9Y468 6/20 0.60
ALDH1A1 P00352 4/20 0.56
HSD17B10 Q99714 2/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
ALOX12 P18054 1/20 0.56
RECQL P46063 1/20 0.56
TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29647831 1.00 MAPT (0.75) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL10736653 0.86 L3MBTL1 (0.72) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL7634005 0.86 MAPT (1.00) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL4028624 0.85 MAPT (0.62) MAPTKMT2AMEN1KDM4EGAA
Bromide SCHEMBL6428429 0.84 MAPT (0.60) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL12210613 0.83 LIPG (0.57) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL16677014 0.83 PTPN1 (0.60) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL1398257 0.83 MAPT (0.67) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL10758335 0.82 MAPT (0.67) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL6773815 0.82 MEN1 (0.57) MAPTKMT2AMEN1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114436892-B Abeta-responsive light-activated fluorescent probe and preparation method and application thereof 中国药科大学 2023-05-23 CN claimed
CN-114436892-A Abeta-responsive light-activated fluorescent probe and preparation method and application thereof 中国药科大学 2022-05-06 CN claimed
CN-110577782-B Building powder coating with mildew-proof performance 安徽群升建筑工程有限公司 2021-09-21 CN claimed
US-10655015-B2 Tire crumb-based bitumen polymer for producing a lower viscosity asphalt with improved tolerance to high temperatures Argopro Group LLC (US) 2020-05-19 US claimed
US-20200095424-A1 TIRE CRUMB-BASED BITUMEN POLYMER FOR PRODUCING A LOWER VISCOSITY ASPHALT WITH IMPROVED TOLERANCE TO HIGH TEMPERATURES Argopro Group LLC 2020-03-26 US claimed
CN-110577782-A building powder coating with mildew-proof performance 安徽群升建筑工程有限公司 2019-12-17 CN claimed
CN-104203944-B Multi-fluorescent substance containing coumarin derivative and diagnostic LED light source micro-fluorescence quantitative biosensor using same 点标生物股份有限公司 2017-03-01 CN claimed
CN-104203944-A Multi-fluorescent substance containing novel coumarin derivative and LED light source micro-fluorescence quantitative biosensor for diagnosis using same ACCOBIOTECH SDN BHD 2014-12-10 CN claimed
US-20140350227-A1 MULTI-FLUORESCENT SUBSTANCE INCLUDING NOVEL COUMARIN DERIVATIVE, AND LED LIGHT SOURCE-BASED MICROFLUORESCENT QUANTITATIVE BIOSENSOR FOR DIAGNOSIS USING SAME ACCOBIOTECH SDN BHD. (MY) 2014-11-27 US claimed
EP-4661058-A1 CLEANING AGENT COMPOSITION AND CLEANING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-12-10 EP disclosed
WO-2025242908-A2 NOVEL COMPOUNDS GENOME THERAPEUTICS LTD (GB) 2025-11-27 WO disclosed
WO-2025133338-A1 QUINOLONE DERIVATVES AGAINST CANCER GENOME THERAPEUTICS LTD (GB) 2025-06-26 WO disclosed
WO-2025125302-A1 NOVEL COMPOUNDS GENOME THERAPEUTICS LTD (GB) 2025-06-19 WO disclosed
WO-2024074814-A9 COMPOSITION COMPRISING A FUNCTIONALISED DYE AND A DIALLYLAMINE COMONOMER AND USE THEREOF SUBLINO LIMITED (GB) 2025-05-22 WO disclosed
US-4260770-A Naphtholactam dyes CIBA-GEIGY AKTIENGESELLSCHAFT (DE) 1981-04-07 US disclosed
US-4256896-A THIAZOLE, IMIDAZOLINE, AND OXAZOLINE DYES; DISPERSE DYES; ANIONIC DYES; TEXTILES CIBA-GEIGY AKTIENGESELLSCHAFT (DE) 1981-03-17 US disclosed
US-4249010-A FOR POLYESTERS; COLORFASTNESS BAYER AKTIENGESELLSCHAFT (DE) 1981-02-03 US disclosed
US-4201713-A COLORFASTNESS BAYER AKTIENGESELLSCHAFT (DE) 1980-05-06 US disclosed
US-4113718-A Basic azo dyes CIBA-GEIGY CORPORATION (US) 1978-09-12 US disclosed
US-4064136-A FROM A NITRILE, AN ALCOHOL AND ORTHO-SUBSTITUTED AROMATIC AMINE CIBA-GEIGY AG (CH) 1977-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350227-A1 MULTI-FLUORESCENT SUBSTANCE INCLUDING NOVEL COUMARIN DERIVATIVE, AND LED LIGHT SOURCE-BASED MICROFLUORESCENT QUANTITATIVE BIOSENSOR FOR DIAGNOSIS USING SAME FLOT1, FCGR3B, FLNA MAPT 298/4885KMT2A 2442/4885MEN1 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.